Mohammad Zahid, MD
Nephrology · Elgin, ILNPI 1225027873
Payments from drug & device makers
Across 138 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- OPKO Pharmaceuticals, LLC$348
- AstraZeneca$320
- Amgen$290
- Mallinckrodt Hospital Products Inc.$251
- Bayer$241
- Daiichi Sankyo Inc.$206
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,44989%
- Education$29211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 19 | $348 |
| AstraZeneca(2 entities) | 15 | $320 |
| Amgen(2 entities) | 16 | $290 |
| Mallinckrodt Hospital Products Inc. | 8 | $251 |
| Bayer | 12 | $241 |
| Daiichi Sankyo Inc. | 12 | $206 |
| Vanda Pharmaceuticals Inc. | 10 | $187 |
| Akebia Therapeutics Inc | 11 | $187 |
| Vifor Pharma, Inc. | 4 | $101 |
| Travere Therapeutics, Inc. | 6 | $94 |
| Watermark Medical, Inc. | 1 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Ultragenyx Pharmaceutical Inc. | 3 | $62 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $36 |
| Shire North American Group Inc | 2 | $35 |
| GSK | 2 | $31 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $21 |
| AbbVie | 1 | $21 |
| AMAG Pharmaceuticals, Inc. | 1 | $20 |
| Rockwell Medical, Inc. | 1 | $19 |
| Corium, LLC | 2 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Fresenius USA Marketing, Inc. | 1 | $13 |
| Bard Peripheral Vascular, Inc. | 1 | $12 |
How this compares
$2,741 in reported general payments places this provider in the 70th percentile of 524 nephrology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClinisolParenteral Amino Acid 15% No.5 | 52 | $7,167 |
| Sevelamer Carbonate | 13 | $2,999 |
| Nifedipine ErNifedipine | 40 | $1,628 |
| Mycophenolate Mofetil | 11 | $1,364 |
| Bumetanide | 34 | $908 |
| Calcitriol | 66 | $669 |
| Metoprolol Succinate | 12 | $483 |
| Torsemide | 18 | $401 |
| Calcium Acetate | 17 | $390 |
| Allopurinol | 31 | $381 |
| Tamsulosin Hcl | 22 | $352 |
| Potassium Chloride | 14 | $335 |
| Doxazosin Mesylate | 28 | $282 |
| Atorvastatin Calcium | 21 | $200 |
| Furosemide | 24 | $190 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Elgin
- Myles WolfChicago$22.4M
- Suneel UdaniHinsdale$6.8M
- Paul CrawfordEvergreen Park$3.1M
- Beatrice ConcepcionChicago$2.6M
- April KennedyChicago$1.8M
- Khaleel SayeedChicago$1.7M
- Woojin James ChonHines$1.1M
- Mohammed AhmedBolingbrook$1.1M
- Tamara IsakovaChicago$763K
- William WhittierChicago$668K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.